In Vivo Studies of Radiolabeled Monoclonal Antibodies Mc5 and KC4 in Human Breast Cancer
Breast cancer is the most common malignancy in women in the United States, with over 130,000 new cases developing annually(1). Despite improved methods for early detection and treatment, the death rate from breast cancer in the United States has not changed over tbe past 25 years. Nearly all patients who die from breast cancer do so as a result of widespread systemic metastases. Metastatic breast cancer is difficult to detect early and impossible to cure with currently available treatment modalities.
KeywordsBreast Cancer Nude Mouse Tumor Uptake Athymic Nude Mouse Murine Monoclonal Antibody
Unable to display preview. Download preview PDF.
- 4.D. Hofheinz, D. Dienhart, G. Miller,et al., Monoclonal antibody, KC4G3, recognizes a novel, widely expresssed antigen on human epithelial cancers,Proc. Am. Assoc. Cancer. Res. 28:1552(1987).Google Scholar
- 7.R. L. Ceriani, E.H. Rosenbaum, M. Chandler, T.T. Trujillo, B. Myers and M. Sakada, Role of circulating human mammary epithelial antigens(HME-Ags) as serum markers for breast cancer. In “Tumor markers and their significance in the management of breast cancer.” IP, C.. ed. A.R. Liss. ed.. 1986. pp.3–19.Google Scholar
- 11.H. G. Boxenbaum, S. Riegelman, and R. M. Elashoff, Statistical estimations in pharmacokinetics,J. Pharmacokinet. Biopharmaceut. 2:123–148(1974).Google Scholar
- 12.A. H. Epenetos, S. Mather, M. Granowska,et al., Targeting of iodine-123-labeled tumor-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumors,Lancet 2:99–1006(1982).Google Scholar
- 17.D. Dienhart, R. Schmelter, J. Lear,et al., Imaging and treatment of non-small cell lung cancer with monoclonal antibody KC4G3,Proc. Am. Soc. Clin. Oncol. 6:184(1987).Google Scholar